# Lucid Diagnostics Inc. (LUCD) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Lucid Diagnostics Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/LUCD/mda/fy2025/): filed 2026-03-25; accession 0001437749-26-009805 (https://www.sec.gov/Archives/edgar/data/1799011/000143774926009805/lucd20251231_10k.htm); latest 10-K
- [FY 2024 MD&A](/company/LUCD/mda/fy2024/): filed 2025-03-24; accession 0001641172-25-000205 (https://www.sec.gov/Archives/edgar/data/1799011/000164117225000205/form10-k.htm)
- [FY 2023 MD&A](/company/LUCD/mda/fy2023/): filed 2024-03-25; accession 0001493152-24-011161 (https://www.sec.gov/Archives/edgar/data/1799011/000149315224011161/form10-k.htm)
- [FY 2022 MD&A](/company/LUCD/mda/fy2022/): filed 2023-03-14; accession 0001493152-23-007482 (https://www.sec.gov/Archives/edgar/data/1799011/000149315223007482/form10-k.htm)
- [FY 2021 MD&A](/company/LUCD/mda/fy2021/): filed 2022-04-06; accession 0001493152-22-009199 (https://www.sec.gov/Archives/edgar/data/1799011/000149315222009199/form10-k.htm)

Back to /company/LUCD/